Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;398(5):5757-5771.
doi: 10.1007/s00210-024-03665-9. Epub 2024 Nov 28.

Unveiling the anxiolytic and analgesic effects of citronellal in Swiss mice: in vivo and in silico insights into COX and GABAA receptor pathways

Affiliations

Unveiling the anxiolytic and analgesic effects of citronellal in Swiss mice: in vivo and in silico insights into COX and GABAA receptor pathways

Muhammad Torequl Islam et al. Naunyn Schmiedebergs Arch Pharmacol. 2025 May.

Abstract

This study aims to evaluate the analgesic and anxiolytic effects of citronellal (CTL) in Swiss mice using two new sensitive and economic mouse models along with possible molecular mechanisms through in silico studies. For this, we employed marble displacement and spiked-field apparatus to check the anxiolytic and analgesic effects, respectively. In silico studies were done against cyclooxygenase (COX) enzymes and GABAA receptor subunits. Findings suggest that the test sample CTL significantly reduced the number of marbles displaces (NMD), square crosses (NSC), paw massages (NPM), and escaping attempts (NEA) in animals than the control group. CTL exhibited better effects in the perforated-field study compared to the reference drug diclofenac sodium. In both cases, CTL (200 mg/kg) significantly reduced the test parameters when combined with the standard drugs (diazepam or diclofenac sodium). In in silico studies, CTL showed binding affinities of - 5.5, - 5.2, - 4.8, and - 4.8 kcal/mol with the COX1, COX2, and GABAA receptors (α2 and α3 subunits), respectively. Taken together, CTL may exert anxiolytic- analgesic-like effects on mice, possibly through the GABAA receptor and COXs interaction pathways. These new tools might be used to check the anxiolytic and analgesic properties of a wide variety of test substances.

Keywords: Anxiety; Bioactive compound; Marble displacement; Pain; Spiked-field.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by the Animal Ethics Committee of Khulna University (KUAEC-2023–05-09). No anesthetic or surgical procedures were used for this study. We checked only the behavioral parameters after the treatment; therefore, this study did not require any medication to overcome or reduce the suffering of the experimental animals. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

Cited by

References

    1. Abbasi-Maleki S, Kadkhoda Z, Taghizad-Farid R (2020) The antidepressant-like effects of Origanum majorana essential oil on mice through monoaminergic modulation using the forced swimming test. J Tradit Complement Med 10(4):327–335 - DOI - PubMed
    1. Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI, Aja PM (2023) Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep 13(1):13398. https://doi.org/10.1038/s41598-023-40160-2 - DOI - PubMed - PMC
    1. Akpınar Ş, Karadağ MG (2022) Is vitamin D important in anxiety or depression? What is the truth? Curr Nutr Rep 11(4):675–681. https://doi.org/10.1007/s13668-022-00441-0 - DOI - PubMed - PMC
    1. Akter A, Islam F, Bepary S, Al-Amin M, Begh MZA, Islam MAFU, ... Ullah MF (2022) CNS depressant activities of Averrhoa carambola leaves extract in thiopental-sodium model of Swiss albino mice: implication for neuro-modulatory properties. Biologia 77(5):1337–1346
    1. Andrade EL, Bento AF, Cavalli J, Oliveira SK, Schwanke RC, Siqueira JM, Freitas CS, Marcon R, Calixto JB (2016) Non-clinical studies in the process of new drug development-Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies. Braz J Med Biol Res 12:49

LinkOut - more resources